Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gene Expression Profiling | 14 | 2024 | 9538 | 0.480 |
Why?
|
| Burns | 7 | 2014 | 1899 | 0.410 |
Why?
|
| Proteome | 7 | 2024 | 1890 | 0.380 |
Why?
|
| RNA Splice Sites | 1 | 2012 | 213 | 0.360 |
Why?
|
| Alternative Splicing | 3 | 2012 | 1105 | 0.360 |
Why?
|
| Gene Expression Regulation | 8 | 2016 | 11928 | 0.350 |
Why?
|
| Leukocytes | 5 | 2011 | 2035 | 0.340 |
Why?
|
| Computational Biology | 6 | 2016 | 3568 | 0.320 |
Why?
|
| Proteomics | 6 | 2014 | 3912 | 0.300 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 10 | 2012 | 3800 | 0.290 |
Why?
|
| Blood Proteins | 6 | 2010 | 1191 | 0.240 |
Why?
|
| Sequence Analysis, RNA | 2 | 2012 | 2040 | 0.240 |
Why?
|
| Software | 5 | 2016 | 4478 | 0.220 |
Why?
|
| Lipopolysaccharides | 4 | 2024 | 2219 | 0.220 |
Why?
|
| Species Specificity | 2 | 2024 | 2415 | 0.200 |
Why?
|
| Genome, Human | 3 | 2011 | 4446 | 0.180 |
Why?
|
| Inflammation | 8 | 2024 | 10873 | 0.180 |
Why?
|
| Pseudomonas Infections | 4 | 2011 | 623 | 0.150 |
Why?
|
| Transcription, Genetic | 2 | 2011 | 7608 | 0.150 |
Why?
|
| Databases, Genetic | 3 | 2014 | 1758 | 0.150 |
Why?
|
| Exons | 3 | 2012 | 2394 | 0.140 |
Why?
|
| Mass Spectrometry | 5 | 2014 | 2202 | 0.140 |
Why?
|
| Databases, Nucleic Acid | 1 | 2016 | 204 | 0.130 |
Why?
|
| Chromatography, Liquid | 4 | 2010 | 996 | 0.120 |
Why?
|
| Oxygen Isotopes | 3 | 2010 | 43 | 0.120 |
Why?
|
| Trauma Severity Indices | 2 | 2014 | 479 | 0.110 |
Why?
|
| Multiple Organ Failure | 2 | 2014 | 388 | 0.110 |
Why?
|
| Genome-Wide Association Study | 1 | 2012 | 12795 | 0.100 |
Why?
|
| Endotoxins | 2 | 2011 | 519 | 0.090 |
Why?
|
| Reference Standards | 2 | 2012 | 1014 | 0.090 |
Why?
|
| Chromatography, Ion Exchange | 3 | 2005 | 293 | 0.090 |
Why?
|
| Glutathione Transferase | 1 | 2011 | 564 | 0.080 |
Why?
|
| Molecular Sequence Annotation | 1 | 2012 | 527 | 0.080 |
Why?
|
| Wound Infection | 1 | 2011 | 243 | 0.080 |
Why?
|
| Isotope Labeling | 1 | 2010 | 394 | 0.080 |
Why?
|
| RNA | 3 | 2010 | 2720 | 0.080 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2011 | 648 | 0.080 |
Why?
|
| Wounds and Injuries | 5 | 2010 | 2517 | 0.080 |
Why?
|
| Benchmarking | 1 | 2014 | 1057 | 0.070 |
Why?
|
| Muscles | 1 | 2012 | 1582 | 0.070 |
Why?
|
| Genes, Regulator | 1 | 2007 | 373 | 0.070 |
Why?
|
| Adaptive Immunity | 1 | 2011 | 733 | 0.070 |
Why?
|
| Neoplasm, Residual | 1 | 2011 | 1015 | 0.070 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2005 | 1276 | 0.070 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 2 | 2005 | 267 | 0.070 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2008 | 340 | 0.060 |
Why?
|
| Microfluidics | 1 | 2010 | 672 | 0.060 |
Why?
|
| High-Throughput Screening Assays | 1 | 2011 | 942 | 0.060 |
Why?
|
| Genomics | 3 | 2016 | 5926 | 0.060 |
Why?
|
| Muscle, Skeletal | 2 | 2011 | 4978 | 0.060 |
Why?
|
| Pan troglodytes | 1 | 2024 | 224 | 0.060 |
Why?
|
| Peptides | 2 | 2014 | 4354 | 0.060 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2016 | 3671 | 0.050 |
Why?
|
| Immunity, Innate | 3 | 2011 | 3080 | 0.050 |
Why?
|
| Bacterial Infections | 1 | 2011 | 1397 | 0.050 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2005 | 505 | 0.050 |
Why?
|
| Transplantation, Homologous | 1 | 2011 | 4833 | 0.050 |
Why?
|
| Cell Separation | 1 | 2008 | 1728 | 0.050 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2005 | 352 | 0.050 |
Why?
|
| Critical Illness | 2 | 2014 | 2756 | 0.050 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2008 | 820 | 0.050 |
Why?
|
| Sheep | 1 | 2024 | 1451 | 0.050 |
Why?
|
| Critical Care | 1 | 2014 | 2715 | 0.050 |
Why?
|
| Drosophila melanogaster | 3 | 2007 | 1726 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2016 | 18349 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2014 | 6283 | 0.040 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2011 | 1642 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 4620 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2005 | 1737 | 0.040 |
Why?
|
| Proteins | 1 | 2014 | 6009 | 0.040 |
Why?
|
| Humans | 27 | 2024 | 768166 | 0.040 |
Why?
|
| Cattle | 1 | 2024 | 3819 | 0.040 |
Why?
|
| Trypsin | 2 | 2010 | 491 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2012 | 12800 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2007 | 1752 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2010 | 5151 | 0.040 |
Why?
|
| Neutrophils | 1 | 2010 | 3786 | 0.040 |
Why?
|
| Drosophila Proteins | 2 | 2005 | 1712 | 0.040 |
Why?
|
| Receptors, Cell Surface | 2 | 2005 | 2819 | 0.040 |
Why?
|
| Monocytes | 1 | 2006 | 2605 | 0.030 |
Why?
|
| Reproducibility of Results | 7 | 2011 | 20227 | 0.030 |
Why?
|
| Liver | 1 | 2012 | 7577 | 0.030 |
Why?
|
| Cluster Analysis | 3 | 2010 | 2732 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2007 | 3467 | 0.030 |
Why?
|
| Swine | 1 | 2024 | 5995 | 0.030 |
Why?
|
| Algorithms | 2 | 2012 | 14164 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2011 | 5717 | 0.030 |
Why?
|
| Oxygen | 1 | 2005 | 4270 | 0.030 |
Why?
|
| Gene Expression | 1 | 2005 | 7598 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2010 | 6229 | 0.020 |
Why?
|
| Disease Susceptibility | 2 | 2011 | 1793 | 0.020 |
Why?
|
| Animals | 8 | 2024 | 169246 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2011 | 369 | 0.020 |
Why?
|
| Immunosorbent Techniques | 1 | 2010 | 174 | 0.020 |
Why?
|
| Aldehydes | 1 | 2011 | 170 | 0.020 |
Why?
|
| Sepsis | 1 | 2024 | 2608 | 0.020 |
Why?
|
| Toll-Like Receptors | 2 | 2005 | 582 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 6082 | 0.020 |
Why?
|
| Genes, Mitochondrial | 1 | 2010 | 59 | 0.020 |
Why?
|
| Biotinylation | 1 | 2010 | 185 | 0.020 |
Why?
|
| Specimen Handling | 2 | 2005 | 708 | 0.020 |
Why?
|
| Mice | 4 | 2024 | 82029 | 0.020 |
Why?
|
| Genes, Immunoglobulin | 1 | 2010 | 286 | 0.020 |
Why?
|
| Acute-Phase Proteins | 1 | 2010 | 252 | 0.020 |
Why?
|
| Isotopes | 1 | 2009 | 125 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2006 | 10266 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2010 | 472 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 2011 | 563 | 0.020 |
Why?
|
| Adult | 7 | 2014 | 223646 | 0.020 |
Why?
|
| Rats | 1 | 2024 | 23760 | 0.020 |
Why?
|
| Age Distribution | 1 | 2014 | 2873 | 0.020 |
Why?
|
| Time Factors | 5 | 2010 | 40218 | 0.020 |
Why?
|
| Troponin C | 1 | 2007 | 48 | 0.020 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2007 | 147 | 0.020 |
Why?
|
| RNA, Untranslated | 1 | 2011 | 455 | 0.020 |
Why?
|
| DNA Primers | 1 | 2011 | 2828 | 0.020 |
Why?
|
| Chemical Fractionation | 1 | 2006 | 61 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2008 | 845 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2011 | 1968 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 18065 | 0.020 |
Why?
|
| Kidney Cortex | 1 | 2005 | 168 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2011 | 1474 | 0.020 |
Why?
|
| Receptors, Cytokine | 1 | 2006 | 258 | 0.020 |
Why?
|
| Male | 7 | 2014 | 364719 | 0.020 |
Why?
|
| Electrophoresis, Capillary | 1 | 2005 | 63 | 0.020 |
Why?
|
| Peptide Mapping | 1 | 2005 | 260 | 0.010 |
Why?
|
| Suppression, Genetic | 1 | 2005 | 190 | 0.010 |
Why?
|
| Female | 7 | 2014 | 397192 | 0.010 |
Why?
|
| Longitudinal Studies | 2 | 2011 | 14783 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2011 | 2937 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 2010 | 1613 | 0.010 |
Why?
|
| Fourier Analysis | 1 | 2005 | 439 | 0.010 |
Why?
|
| Blood Loss, Surgical | 1 | 2007 | 642 | 0.010 |
Why?
|
| Blood Specimen Collection | 1 | 2004 | 238 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2011 | 22291 | 0.010 |
Why?
|
| Enterotoxins | 1 | 2004 | 366 | 0.010 |
Why?
|
| Sensitivity and Specificity | 2 | 2011 | 14729 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2007 | 3590 | 0.010 |
Why?
|
| Principal Component Analysis | 1 | 2005 | 948 | 0.010 |
Why?
|
| Spleen | 1 | 2007 | 2295 | 0.010 |
Why?
|
| Reference Values | 1 | 2009 | 4938 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2011 | 5902 | 0.010 |
Why?
|
| Virulence | 1 | 2005 | 1297 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4580 | 0.010 |
Why?
|
| Base Sequence | 1 | 2011 | 12421 | 0.010 |
Why?
|
| Equipment Design | 1 | 2008 | 3522 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2006 | 2923 | 0.010 |
Why?
|
| Length of Stay | 1 | 2014 | 6498 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 2709 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2014 | 5349 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2010 | 4035 | 0.010 |
Why?
|
| Virulence Factors | 1 | 2003 | 502 | 0.010 |
Why?
|
| Antigens, Bacterial | 1 | 2004 | 1150 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2014 | 54926 | 0.010 |
Why?
|
| Middle Aged | 5 | 2014 | 223492 | 0.010 |
Why?
|
| DNA | 1 | 2010 | 7214 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2011 | 14488 | 0.010 |
Why?
|
| Adolescent | 3 | 2014 | 89169 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2005 | 4146 | 0.010 |
Why?
|
| Incidence | 1 | 2014 | 21538 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2010 | 5107 | 0.010 |
Why?
|
| Acute Disease | 1 | 2005 | 7243 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2010 | 23645 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2010 | 9263 | 0.010 |
Why?
|
| Age Factors | 1 | 2010 | 18412 | 0.010 |
Why?
|
| Patient Selection | 1 | 2005 | 4260 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 39348 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2004 | 13421 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 17622 | 0.010 |
Why?
|
| Cytokines | 1 | 2006 | 7453 | 0.010 |
Why?
|
| Genotype | 1 | 2005 | 13045 | 0.010 |
Why?
|
| Prognosis | 1 | 2010 | 30010 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2010 | 26379 | 0.000 |
Why?
|
| Research Design | 1 | 2004 | 6211 | 0.000 |
Why?
|
| Infant | 1 | 2010 | 36535 | 0.000 |
Why?
|
| Young Adult | 1 | 2014 | 60066 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2010 | 42669 | 0.000 |
Why?
|
| Aging | 1 | 2005 | 8744 | 0.000 |
Why?
|
| United States | 1 | 2014 | 73039 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2014 | 81762 | 0.000 |
Why?
|
| Aged | 2 | 2005 | 171504 | 0.000 |
Why?
|
| Child | 1 | 2010 | 80917 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2005 | 59629 | 0.000 |
Why?
|
Concepts
(183)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(12)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_